vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and MARKEL GROUP INC. (MKL). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $3.6B, roughly 1.5× MARKEL GROUP INC.). MARKEL GROUP INC. runs the higher net margin — 16.1% vs 7.9%, a 8.2% gap on every dollar of revenue. On growth, Fresenius Medical Care AG posted the faster year-over-year revenue change (-0.3% vs -6.9%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
MARKEL GROUP INC.MKLEarnings & Financial Report
Markel Group Inc. is a group of companies headquartered in Richmond, Virginia, and originally founded in 1930 as an insurance company.
FMS vs MKL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $3.6B |
| Net Profit | $434.2M | $576.8M |
| Gross Margin | 27.4% | — |
| Operating Margin | 11.7% | 22.2% |
| Net Margin | 7.9% | 16.1% |
| Revenue YoY | -0.3% | -6.9% |
| Net Profit YoY | 240.4% | 5.0% |
| EPS (diluted) | — | $48.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $3.6B | ||
| Q3 25 | — | $3.9B | ||
| Q2 25 | — | $4.6B | ||
| Q1 25 | — | $3.4B | ||
| Q4 24 | $5.5B | $3.8B | ||
| Q3 24 | — | $4.6B | ||
| Q2 24 | — | $3.7B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $434.2M | $576.8M | ||
| Q3 25 | — | $751.3M | ||
| Q2 25 | — | $657.1M | ||
| Q1 25 | — | $121.7M | ||
| Q4 24 | $127.6M | $549.2M | ||
| Q3 24 | — | $905.0M | ||
| Q2 24 | — | $267.7M | ||
| Q1 24 | — | $1.0B |
| Q4 25 | 27.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 11.7% | 22.2% | ||
| Q3 25 | — | 25.7% | ||
| Q2 25 | — | 24.1% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | 5.1% | 15.5% | ||
| Q3 24 | — | 29.7% | ||
| Q2 24 | — | 11.1% | ||
| Q1 24 | — | 29.9% |
| Q4 25 | 7.9% | 16.1% | ||
| Q3 25 | — | 19.1% | ||
| Q2 25 | — | 14.3% | ||
| Q1 25 | — | 3.6% | ||
| Q4 24 | 2.3% | 14.3% | ||
| Q3 24 | — | 19.6% | ||
| Q2 24 | — | 7.2% | ||
| Q1 24 | — | 23.0% |
| Q4 25 | — | $48.22 | ||
| Q3 25 | — | $59.25 | ||
| Q2 25 | — | $49.67 | ||
| Q1 25 | — | $12.08 | ||
| Q4 24 | — | $39.02 | ||
| Q3 24 | — | $66.25 | ||
| Q2 24 | — | $18.62 | ||
| Q1 24 | — | $75.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $4.0B |
| Total DebtLower is stronger | — | $4.3B |
| Stockholders' EquityBook value | $15.4B | $18.6B |
| Total Assets | $33.5B | $68.9B |
| Debt / EquityLower = less leverage | — | 0.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $4.0B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | $1.3B | $3.7B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | $3.5B | ||
| Q1 24 | — | $3.6B |
| Q4 25 | — | $4.3B | ||
| Q3 25 | — | $4.3B | ||
| Q2 25 | — | $4.4B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.4B | ||
| Q2 24 | — | $4.4B | ||
| Q1 24 | — | $3.9B |
| Q4 25 | $15.4B | $18.6B | ||
| Q3 25 | — | $18.0B | ||
| Q2 25 | — | $17.3B | ||
| Q1 25 | — | $17.1B | ||
| Q4 24 | $17.0B | $16.9B | ||
| Q3 24 | — | $17.0B | ||
| Q2 24 | — | $15.9B | ||
| Q1 24 | — | $15.7B |
| Q4 25 | $33.5B | $68.9B | ||
| Q3 25 | — | $67.4B | ||
| Q2 25 | — | $66.8B | ||
| Q1 25 | — | $64.6B | ||
| Q4 24 | $36.3B | $61.9B | ||
| Q3 24 | — | $62.3B | ||
| Q2 24 | — | $59.7B | ||
| Q1 24 | — | $57.3B |
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.25× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $662.2M |
| Free Cash FlowOCF − Capex | — | $599.1M |
| FCF MarginFCF / Revenue | — | 16.7% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | 6.67× | 1.15× |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.6B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $662.2M | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $504.4M | ||
| Q1 25 | — | $376.2M | ||
| Q4 24 | $2.6B | $493.9M | ||
| Q3 24 | — | $890.8M | ||
| Q2 24 | — | $578.6M | ||
| Q1 24 | — | $630.7M |
| Q4 25 | — | $599.1M | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $453.8M | ||
| Q1 25 | — | $335.5M | ||
| Q4 24 | — | $420.0M | ||
| Q3 24 | — | $838.9M | ||
| Q2 24 | — | $521.4M | ||
| Q1 24 | — | $558.7M |
| Q4 25 | — | 16.7% | ||
| Q3 25 | — | 29.6% | ||
| Q2 25 | — | 9.9% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | — | 10.9% | ||
| Q3 24 | — | 18.2% | ||
| Q2 24 | — | 14.1% | ||
| Q1 24 | — | 12.5% |
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | 6.67× | 1.15× | ||
| Q3 25 | — | 1.62× | ||
| Q2 25 | — | 0.77× | ||
| Q1 25 | — | 3.09× | ||
| Q4 24 | 20.20× | 0.90× | ||
| Q3 24 | — | 0.98× | ||
| Q2 24 | — | 2.16× | ||
| Q1 24 | — | 0.62× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMS
Segment breakdown not available.
MKL
| Industrial | $1.6B | 45% |
| Consumer And Other | $958.3M | 27% |
| Financial | $737.0M | 21% |
| Other | $198.8M | 6% |
| Corporate Operations | $52.0M | 1% |
| Revenue From Contract With Customer | $10.5M | 0% |
